MaxLinear, Inc. (MXL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MXL SEC filings page.
MaxLinear, Inc. (MXL) reported $568.9M in revenue over the twelve months to Jun 30, 2026, up 50.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The 2025 rebound restored some sales, but stable gross margins and heavy operating costs still leave the business structurally loss-making.
From FY2022 to FY2025, gross margin stayed in a narrow54.0% -58.0% band while revenue fell sharply, pointing to a volume-and-scale problem rather than deteriorating product-level economics. In FY2025, operating cash flow was$19.6M and free cash flow was$7.0M even as the company reported a net loss of$136.7M , meaning noncash charges and working-capital movements improved cash before reported earnings recovered.
The cost structure is the central constraint: FY2025 gross profit was
Short-term balance-sheet flexibility has narrowed: the current ratio fell from 2.2x in FY2023 to 1.3x in FY2025. Debt-to-equity stayed comparatively low at 0.3x, so the tighter cushion did not come from a major increase in borrowing; total equity instead fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of MaxLinear, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
MaxLinear, Inc. held $72.8M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $19.6M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and MaxLinear, Inc. scores 86/100 among other emerging companies.
MaxLinear, Inc. had 86M shares outstanding at the end of fiscal year 2025, against 85M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and MaxLinear, Inc. scores 63/100 among other emerging companies.
MaxLinear, Inc. spent $208.6M on research and development in fiscal year 2025, which was 35.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and MaxLinear, Inc. scores 67/100 among other emerging companies.
MaxLinear, Inc. reported revenue of $467.6M in fiscal year 2025, against $360.5M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and MaxLinear, Inc. scores 21/100 among other emerging companies.
Not available for MaxLinear, Inc., and counted as zero in the overall score.
MaxLinear, Inc.'s cash, cash equivalents and investments came to $72.8M at the end of fiscal year 2025, against $344.5M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and MaxLinear, Inc. scores 28/100 among other emerging companies.
MaxLinear, Inc. scores 16.01, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($9.6B) relative to total liabilities ($344.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
MaxLinear, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
MaxLinear, Inc. reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
MaxLinear, Inc. reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
MaxLinear, Inc. generated $168.8M in revenue in Q2 2026. This represents an increase of 55.2% from the same quarter a year earlier. Against the prior quarter it is up 23.1%.
MaxLinear, Inc.'s EBITDA was $4.9M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 131.8% from the same quarter a year earlier. Against the prior quarter it is up 177.5%.
MaxLinear, Inc. reported $1.8M in net income in Q2 2026. This represents an increase of 106.6% from the same quarter a year earlier. Against the prior quarter it is up 103.9%.
MaxLinear, Inc. earned $0.02 per diluted share (EPS) in Q2 2026. This represents an increase of 106.5% from the same quarter a year earlier. Against the prior quarter it is up 103.8%.
Cash & Balance Sheet
MaxLinear, Inc. generated $2.5M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 73.5% from the same quarter a year earlier. Against the prior quarter it is up 124.1%.
MaxLinear, Inc. held $64.8M in cash against $123.9M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
MaxLinear, Inc.'s gross margin was 57.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
MaxLinear, Inc.'s operating margin was -2.5% in Q2 2026, reflecting core business profitability. This is up 20.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.1 percentage points.
MaxLinear, Inc.'s net profit margin was 1.0% in Q2 2026, showing the share of revenue converted to profit. This is up 25.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 33.9 percentage points.
MaxLinear, Inc.'s ROE was 0.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 5.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.3 percentage points.
Capital Allocation
MaxLinear, Inc. invested $56.0M in research and development in Q2 2026. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 5.4%.
MaxLinear, Inc. invested $2.3M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 99.5% from the same quarter a year earlier. Against the prior quarter it is up 68.9%.
Not reported for Q2 2026.
MXL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $168.8M+55.2% | $137.2M+43.0% | $136.4M+48.0% | $126.5M+55.9% | $108.8M+18.3% | $95.9M+0.7% | $92.2M-26.5% | $81.1M-40.2% |
| Cost of Revenue | $71.2M+50.5% | $58.3M+38.5% | $57.9M+41.4% | $54.6M+47.4% | $47.3M+13.1% | $42.1M-8.5% | $40.9M-28.0% | $37.0M-39.9% |
| Gross Profit | $97.7M+58.7% | $78.9M+46.5% | $78.6M+53.3% | $71.9M+63.1% | $61.5M+22.6% | $53.8M+9.3% | $51.2M-25.2% | $44.1M-40.4% |
| R&D Expenses | $56.0M+18.7% | $53.2M-4.1% | $51.7M+0.8% | $54.3M+3.1% | $47.2M-16.5% | $55.5M-14.4% | $51.3M-21.4% | $52.6M-20.7% |
| SG&A Expenses | $45.8M+37.1% | $42.5M+16.0% | $42.0M+10.2% | $47.7M+58.1% | $33.4M-0.7% | $36.6M+0.3% | $38.1M+10.8% | $30.2M+18.7% |
| Operating Income | -$4.2M+83.0% | -$17.2M+62.7% | -$14.9M+63.8% | -$41.3M+38.1% | -$24.6M+39.7% | -$46.1M+38.2% | -$41.2M+1.4% | -$66.7M-274.6% |
| EBITDA | $4.9M+131.8% | -$6.3M+82.1% | -$389K+98.5% | -$32.3M+43.0% | -$15.3M+47.7% | -$34.9M+39.7% | -$25.5M-22.5% | -$56.6M-1797.0% |
| Interest Expense | $2.3M-9.7% | $2.2M-12.3% | $2.4M-14.7% | $2.6M-0.2% | $2.5M-7.2% | $2.5M-7.6% | $2.8M-3.7% | $2.7M-2.2% |
| Income Tax | -$8.3M-101.9% | $26.5M+3625.0% | -$2.9M-117.1% | $2.1M+131.2% | -$4.1M-99.8% | $711K+140.4% | $17.0M+511.9% | -$6.7M-297.5% |
| Net Income | $1.8M+106.6% | -$45.1M+9.2% | -$14.9M+74.2% | -$45.5M+40.0% | -$26.6M+32.3% | -$49.7M+31.2% | -$57.8M-50.2% | -$75.8M-90.3% |
| EPS (Basic) | $0.02+106.5% | -$0.52+10.3% | -$0.17+75.0% | -$0.52+42.2% | -$0.31+34.0% | -$0.58+34.1% | -$0.68-41.7% | -$0.90-83.7% |
| EPS (Diluted) | $0.02+106.5% | -$0.52+10.3% | -$0.17+75.0% | -$0.52+42.2% | -$0.31+34.0% | -$0.58+34.1% | -$0.68-41.7% | -$0.90-83.7% |
| Diluted Shares (Avg) | 97M+12.4% | 88M+2.7% | N/A | 87M+3.7% | 87M+3.8% | 85M+3.5% | N/A | 84M+3.5% |
MXL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $822.6M-4.8% | $771.3M-9.8% | $796.4M-7.9% | $808.1M-9.7% | $863.7M-11.2% | $855.3M-17.0% | $864.6M-20.0% | $895.3M-18.9% |
| Current Assets | $298.7M-9.5% | $249.4M-22.1% | $248.8M-23.1% | $284.1M-13.4% | $330.1M-17.0% | $320.4M-27.9% | $323.4M-33.7% | $328.3M-35.5% |
| Cash & Equivalents | $64.8M-40.3% | $61.1M-40.6% | $72.8M-38.6% | $111.9M-24.7% | $108.6M-41.3% | $102.8M-46.4% | $118.6M-36.7% | $148.5M-20.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0-100.0% |
| Inventory | $105.5M+22.6% | $85.8M-0.2% | $78.1M-13.5% | $86.3M-10.1% | $86.0M-9.2% | $86.0M-10.5% | $90.3M-9.6% | $96.1M-16.4% |
| Accounts Receivable | $51.0M-51.8% | $40.9M-58.7% | $46.1M-46.0% | $52.9M+10.4% | $105.8M+24.6% | $98.9M-21.6% | $85.5M-49.9% | $47.9M-69.7% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% | $318.6M0.0% |
| Total Liabilities | $337.7M-10.0% | $317.1M-12.4% | $344.5M-1.1% | $343.4M+1.5% | $375.4M+5.5% | $362.1M-7.8% | $348.4M-11.6% | $338.4M-15.6% |
| Current Liabilities | $168.1M-21.3% | $146.7M-25.5% | $186.0M+2.0% | $183.6M+8.9% | $213.5M+12.2% | $196.9M-12.0% | $182.3M-17.9% | $168.6M-27.6% |
| Non-Current Liabilities | $169.6M+4.8% | $170.4M+3.2% | $158.5M-4.6% | $159.9M-5.9% | $161.9M-2.3% | $165.2M-2.1% | $166.1M-3.4% | $169.8M+1.0% |
| Long-Term Debt | $123.9M+0.5% | $123.8M+0.5% | $123.6M+0.5% | $123.5M+0.5% | $123.3M+0.5% | $123.2M+0.5% | $123.0M+0.5% | $122.8M+0.5% |
| Total Equity | $484.8M-0.7% | $454.2M-7.9% | $451.9M-12.5% | $464.7M-16.5% | $488.3M-20.9% | $493.2M-22.7% | $516.3M-24.8% | $556.9M-20.7% |
| Retained Earnings | -$543.8M-23.6% | -$545.5M-32.0% | -$500.4M-37.6% | -$485.5M-58.7% | -$440.0M-91.2% | -$413.4M-116.6% | -$363.7M-206.9% | -$305.9M-282.2% |
MXL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.8M-54.2% | -$8.9M+22.2% | $10.4M+137.4% | $10.1M+132.9% | $10.5M+489.1% | -$11.4M-171.4% | -$27.8M-68.0% | -$30.7M-140.2% |
| Depreciation & Amortization | $9.0M-3.1% | $10.9M-1.9% | $10.8M-7.9% | $9.0M-11.2% | $9.3M-19.7% | $11.1M-33.2% | $11.7M-29.4% | $10.1M-31.7% |
| Stock-Based Compensation | $27.5M+109.6% | $20.0M-12.6% | N/A | $21.5M+68.2% | $13.1M-24.5% | $22.9M+34.3% | N/A | $12.8M+149.9% |
| Capital Expenditures | $2.3M+99.5% | $1.4M-30.4% | $3.7M+69.1% | $5.7M+38.6% | $1.2M-61.1% | $2.0M-76.2% | $2.2M+72.1% | $4.1M+114.4% |
| Free Cash Flow | $2.5M-73.5% | -$10.3M+23.4% | $6.7M+122.3% | $4.4M+112.6% | $9.3M+263.2% | -$13.4M-275.5% | -$30.0M-68.3% | -$34.9M-136.9% |
| Investing Cash Flow | -$3.1M+57.3% | -$4.2M-113.1% | -$3.7M-22.9% | -$6.7M-13.3% | -$7.4M-27.5% | -$2.0M+77.2% | -$3.0M-120.2% | -$6.0M-128.8% |
| Financing Cash Flow | $1.6M-22.6% | $2.3M+206.4% | -$18.6M-1409.9% | $15K+125.9% | $2.1M+2.6% | -$2.1M-1.8% | $1.4M+21.3% | -$58K+99.7% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MXL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.8%+1.3pp | 57.5%+1.4pp | 57.6%+2.0pp | 56.9%+2.5pp | 56.5%+2.0pp | 56.1%+4.4pp | 55.6%+0.9pp | 54.4%-0.2pp |
| Operating Margin | -2.5%+20.1pp | -12.5%+35.5pp | -10.9%+33.8pp | -32.6%+49.6pp | -22.6%+21.7pp | -48.0%+30.3pp | -44.7%-11.4pp | -82.3%-69.2pp |
| Net Margin | 1.0%+25.5pp | -32.9%+18.9pp | -10.9%+51.8pp | -36.0%+57.5pp | -24.4%+18.3pp | -51.8%+24.1pp | -62.7%-32.0pp | -93.4%-64.1pp |
| Return on Equity | 0.4%+5.8pp | -9.9%+0.1pp | -3.3%+7.9pp | -9.8%+3.8pp | -5.4%+0.9pp | -10.1%+1.2pp | -11.2%-5.6pp | -13.6%-7.9pp |
| Return on Assets | 0.2%+3.3pp | -5.9%0.0pp | -1.9%+4.8pp | -5.6%+2.8pp | -3.1%+1.0pp | -5.8%+1.2pp | -6.7%-3.1pp | -8.5%-4.8pp |
| Current Ratio | 1.78+0.2x | 1.70+0.1x | 1.34-0.4x | 1.55-0.4x | 1.55-0.5x | 1.63-0.4x | 1.77-0.4x | 1.95-0.2x |
| Debt-to-Equity | 0.260.0x | 0.270.0x | 0.270.0x | 0.270.0x | 0.25+0.1x | 0.25+0.1x | 0.24+0.1x | 0.220.0x |
| Asset Turnover | 0.21+0.1x | 0.18+0.1x | 0.17+0.1x | 0.16+0.1x | 0.130.0x | 0.110.0x | 0.110.0x | 0.090.0x |
| FCF Margin | 1.5%-7.1pp | -7.5%+6.5pp | 4.9%+37.5pp | 3.5%+46.5pp | 8.6%+14.8pp | -14.0%-22.0pp | -32.6%-18.3pp | -43.0%-32.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| MaxLinear, Inc. MXL | FY2025 | $467.6M | -$136.7M | -29.2% | $9.6B | 44/100 |
| nLIGHT, Inc. LASR | FY2025 | $261.3M | -$23.5M | -9.0% | $2.3B | 50/100 |
| Himax Technologies, Inc. HIMX | FY2025 | $945.4M | $49.4M | 5.2% | $2.7B | 35/100 |
| Navitas Semiconductor Corporation NVTS | FY2025 | $45.9M | -$117.0M | N/A | $3.3B | 47/100 |
| Alpha and Omega Semiconductor Limited AOSL | FY2026 | $678.9M | -$42.3M | -6.2% | $916.4M | 45/100 |
| CEVA Inc. CEVA | FY2025 | $109.6M | -$10.6M | -9.7% | $1.0B | 74/100 |
Where MaxLinear, Inc. Ranks
Frequently Asked Questions
What is MaxLinear, Inc.'s annual revenue?
MaxLinear, Inc. (MXL) reported $467.6M in total revenue for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is MaxLinear, Inc.'s revenue growing?
MaxLinear, Inc. (MXL) revenue grew by 29.7% year-over-year, from $360.5M to $467.6M in fiscal year 2025.
Is MaxLinear, Inc. profitable?
No, MaxLinear, Inc. (MXL) reported a net income of -$136.7M in fiscal year 2025, with a net profit margin of -29.2%.
What is MaxLinear, Inc.'s EBITDA?
MaxLinear, Inc. (MXL) had EBITDA of -$82.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does MaxLinear, Inc. have?
As of fiscal year 2025, MaxLinear, Inc. (MXL) had $72.8M in cash and equivalents against $123.6M in long-term debt.
What is MaxLinear, Inc.'s gross margin?
MaxLinear, Inc. (MXL) had a gross margin of 56.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is MaxLinear, Inc.'s operating margin?
MaxLinear, Inc. (MXL) had an operating margin of -27.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is MaxLinear, Inc.'s net profit margin?
MaxLinear, Inc. (MXL) had a net profit margin of -29.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is MaxLinear, Inc.'s return on equity (ROE)?
MaxLinear, Inc. (MXL) has a return on equity of -30.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is MaxLinear, Inc.'s free cash flow?
MaxLinear, Inc. (MXL) generated $7.0M in free cash flow during fiscal year 2025. This represents a 111.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is MaxLinear, Inc.'s operating cash flow?
MaxLinear, Inc. (MXL) generated $19.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are MaxLinear, Inc.'s total assets?
MaxLinear, Inc. (MXL) had $796.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are MaxLinear, Inc.'s capital expenditures?
MaxLinear, Inc. (MXL) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does MaxLinear, Inc. spend on research and development?
MaxLinear, Inc. (MXL) invested $208.6M in research and development during fiscal year 2025.
What is MaxLinear, Inc.'s current ratio?
MaxLinear, Inc. (MXL) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.
What is MaxLinear, Inc.'s debt-to-equity ratio?
MaxLinear, Inc. (MXL) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is MaxLinear, Inc.'s return on assets (ROA)?
MaxLinear, Inc. (MXL) had a return on assets of -17.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is MaxLinear, Inc.'s P/E ratio?
MaxLinear, Inc. (MXL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $9.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is MaxLinear, Inc.'s price-to-sales ratio?
MaxLinear, Inc. (MXL) trades at 16.9x sales, its market capitalization divided by revenue of $568.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $9.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is MaxLinear, Inc.'s Altman Z-Score?
MaxLinear, Inc. (MXL) has an Altman Z-Score of 16.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is MaxLinear, Inc.'s Piotroski F-Score?
MaxLinear, Inc. (MXL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are MaxLinear, Inc.'s earnings high quality?
MaxLinear, Inc. (MXL) reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MaxLinear, Inc. cover its interest payments?
MaxLinear, Inc. (MXL) reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is MaxLinear, Inc.?
MaxLinear, Inc. (MXL) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.